Particularly, in addition to the documented missense Kcnk9 mutations,32,33 the enhancer appears to be another target region for mutation and/or epigenetic alteration screening in patients with suspected Birk-Barel syndrome. Here, KCNK9 is linked to Birk-Barel syndrome.